Sanchez Raymond's most recent trade in Cerevel Therapeutics Holdings Inc was a trade of 87,573 Restricted Stock Units done . Disclosure was reported to the exchange on Jan. 19, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cerevel Therapeutics Holdings | Sanchez Raymond | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2024 | 87,573 | 87,573 | - | - | Restricted Stock Units | |
| Cerevel Therapeutics Holdings | Sanchez Raymond | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Dec 2023 | 10,000 | 538,435 | - | - | Stock Option (Right to Buy) | |
| Cerevel Therapeutics Holdings | Raymond Sanchez | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 42.47 per share. | 26 Dec 2023 | 10,000 | 14,673 | - | 42.5 | 424,700 | Common Stock |
| Cerevel Therapeutics Holdings | Sanchez Raymond | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.50 per share. | 26 Dec 2023 | 10,000 | 24,673 | - | 3.5 | 35,000 | Common Stock |
| Cerevel Therapeutics Holdings | Raymond Sanchez | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2023 | 24,825 | 0 | - | - | Restricted Stock Units | |
| Cerevel Therapeutics Holdings | Raymond Sanchez | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2023 | 24,825 | 24,825 | - | - | Common Stock | |
| Cerevel Therapeutics Holdings | Raymond Sanchez | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 41.42 per share. | 19 Dec 2023 | 10,152 | 14,673 | - | 41.4 | 420,528 | Common Stock |
| Cerevel Therapeutics Holdings | Raymond Sanchez | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 41.39 per share. | 15 Dec 2023 | 7,500 | 0 | - | 41.4 | 310,393 | Common Stock |
| Cerevel Therapeutics Holdings | Sanchez Raymond | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2023 | 7,500 | 123,390 | - | - | Stock Option (Right to Buy) | |
| Cerevel Therapeutics Holdings | Sanchez Raymond | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.88 per share. | 15 Dec 2023 | 7,500 | 7,500 | - | 9.9 | 74,100 | Common Stock |
| Cerevel Therapeutics Holdings | Raymond Sanchez | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 41.37 per share. | 07 Dec 2023 | 10,000 | 0 | - | 41.4 | 413,700 | Common Stock |
| Cerevel Therapeutics Holdings | Sanchez Raymond | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Dec 2023 | 10,000 | 548,435 | - | - | Stock Option (Right to Buy) | |
| Cerevel Therapeutics Holdings | Sanchez Raymond | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.50 per share. | 07 Dec 2023 | 10,000 | 10,000 | - | 3.5 | 35,000 | Common Stock |
| Cerevel Therapeutics Holdings | Raymond Sanchez | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2023 | 97,691 | 97,691 | - | - | Stock Option (Right to Buy) | |
| Cerevel Therapeutics Holdings | Raymond Sanchez | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2023 | 24,825 | 24,825 | - | - | Restricted Stock Units | |
| Cerevel Therapeutics Holdings | Raymond Sanchez | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2021 | 278,637 | 278,637 | - | - | Stock Option (Right to Buy) | |
| Cerevel Therapeutics Holdings | Raymond Sanchez | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Oct 2020 | 130,890 | 130,890 | - | - | Stock Option (Right to Buy) |